Loading...
Loading...
CommonWealth REIT
(“CommonWealth”) today announced that its Board
of Trustees has re-confirmed its prior determination that the best interests
of CommonWealth will be served by CommonWealth continuing the common share
offering and debt tender offer previously announced on February 25, 2013. This
second confirmation is issued to respond to the latest information received by
CommonWealth from Corvex Management LP (“Corvex”) and Related Fund Management,
LLC (“Related”).
The Board of Trustees' decision to re-confirm was made after considering the
amended Schedule 13D that was jointly filed on February 27, 2013 by Corvex and
Related with the Securities and Exchange Commission, including the additional
“open letter” from Corvex and Related and the form of complaint that were
filed as exhibits to that amendment, and the litigation that was subsequently
commenced by Corvex and Related. Commonwealth has included the additional open
letter from Corvex and Related and the form of complaint that Corvex and
Related filed as exhibits to their Schedule 13D amendment as exhibits to a
Form 8-K CommonWealth filed earlier today.
The Corvex and Related documents mentioned above are not the Company's
documents and the Company does not endorse or confirm, and is not responsible
for, their content. Reference to these Corvex and Related documents is
intended only to provide context to today's announcement.
This press release is neither an offer to sell nor a solicitation of an offer
to buy CommonWealth common shares, nor shall there by any sale of these
securities in any state or jurisdiction in which the offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of such state or jurisdiction. The preliminary prospectus
supplement relating to this offering and related prospectus have been filed
with the Securities and Exchange Commission and copies can be obtained by
contacting the offices of Citigroup, c/o Broadridge Financial Solutions, 1155
Long Island Avenue, Edgewood, NY 11717, telephone: (800) 831-9146; BofA
Merrill Lynch, Attn: Prospectus Department, 222 Broadway, New York, NY 10038;
email dg.prospectusrequests@baml.com; UBS Investment Bank, Attn. Prospectus
Department, 299 Park Avenue, New York, NY 10171, telephone (888) 827-7275; or
Morgan Stanley, Attn: Prospectus Department, 180 Varick Street, 2^nd floor,
New York, NY 10014, telephone (866) 718-1649; email:
prospectus@morganstanley.com.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in